Skip to content
Quebec News Tribune – Lifestyle
Author:
Cosmos Health Inc.
Cosmos Health’s Contract Manufacturing Division Surpasses $20 Million in Implied Revenue and $18 Million in Implied Gross Profit Across Its Record 32.7 Million-Unit Production Pipeline
September 28, 2026
Cosmos Health Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma; Orderbook Surges Past 32.7 Million Units, Up 31% Since June
September 15, 2026
Cosmos Health Moves to Tokenize CCX0722 Intellectual Property in Innovative Non-Dilutive Structure, Eyes $562 Billion Weight-Management Market
September 14, 2026
Cosmos Health Secures Additional 2.5 Million Units Under New Five-Year Contract Manufacturing Agreement with Viofar; Total Orderbook Surpasses 27.5 Million Units
September 11, 2026
Cosmos Health Launches C-ScrubVet in the UK, Advancing into the $69 Billion Global Animal Health Market
September 9, 2026
Cosmos Health: A Company Transformed — 2026 Year-to-Date
September 3, 2026
Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders’ Equity Up 12%; $5M Share Repurchase Program Underway
August 19, 2026
Cosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B Channels
July 27, 2026
Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units
July 20, 2026
Cosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market Repurchases
July 17, 2026
←
Previous Page
1
2
3
4
…
7
Next Page
→